1 – 22 of 22
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Tau PET Imaging in Neurodegenerative Disorders
2022) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 63. p.20-26(
- Contribution to journal › Article
- 2021
-
Mark
Solubility of Aβ40 peptide
(
- Contribution to journal › Article
-
Mark
In vivo tau pathology is associated with synaptic loss and altered synaptic function
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
(
- Contribution to journal › Article
- 2019
-
Mark
Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42
2019) In ACS Chemical Neuroscience(
- Contribution to journal › Article
-
Mark
Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Antipsychotic Treatment Associated With Increased Mortality Risk in Patients With Dementia. A Registry-Based Observational Cohort Study
(
- Contribution to journal › Article
-
Mark
Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment : the effect of age at onset
(
- Contribution to journal › Article
- 2018
-
Mark
Fluid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia
2018) p.221-252(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
G-score : A function to solve the puzzle of modeling the protonation states of β-secretase binding pocket
(
- Contribution to journal › Article
- 2017
-
Mark
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Pathological creativity : How popular media connect neurological disease and creative practices
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(25). p.6444-6449(
- Contribution to journal › Article
- 2014
-
Mark
Increased levels of UCHL-1 in cerebrospinal fluid from patients with Alzheimer’s disease.
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2012
-
Mark
Cerebrospinal Fluid Profiles of Amyloid beta-Related Biomarkers in Alzheimer's Disease
(
- Contribution to journal › Article
- 2011
-
Mark
Discriminatory analysis of biochip-derived protein patterns in CSF and plasma in neurodegenerative diseases
(
- Contribution to journal › Article
- 2010
-
Mark
Amyloid beta-Protein Aggregation Produces Highly Reproducible Kinetic Data and Occurs by a Two-Phase Process
(
- Contribution to journal › Article
- 2005
-
Mark
Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses
(
- Contribution to journal › Article
-
Mark
Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Intraneuronal β-amyloid expression downregulates the Akt survival pathway and blunts the stress response
(
- Contribution to journal › Article
- 2004
-
Mark
Oligomerization of Alzheimer's β-Amyloid within Processes and Synapses of Cultured Neurons and Brain
(
- Contribution to journal › Article
- 2003
-
Mark
Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged >= 80 years
(
- Contribution to journal › Article